Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.
about
Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial.Nebulized antibiotics in mechanically ventilated patients: a challenge for translational research from technology to clinical care.
P2860
Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.
@en
type
label
Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.
@en
prefLabel
Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.
@en
P2093
P2860
P50
P356
P1476
Pharmacokinetics of high-dose nebulized amikacin in ventilated critically ill patients.
@en
P2093
P2860
P304
P356
10.1093/JAC/DKW313
P407
P577
2016-08-11T00:00:00Z